Physician-Pharmacist Comanagement of Hypertension: A Randomized, Comparative Trial
Corresponding Author
Dr. Jeff E. Borenstein M.D., M.P.H.
Departments of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Cedars-Sinai Health System, Beverly Hills, California School of Medicine, University of California Los Angeles, Los Angeles, California
Health Services Research Department, Cedars-Sinai Health System, 9100 Wilshire Boulevard, East Tower, Suite 655, Beverly Hills, CA 90212; e-mail: [email protected].Search for more papers by this authorDr. Geneen Graber Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Emmanuel Saltiel Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Pharmacy, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Joel Wallace Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Seonyoung Ryu Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Archi Jackson Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Stephen Deutsch M.D.
Departments of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Scott R. Weingarten M.D., M.PH.
Departments of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Cedars-Sinai Health System, Beverly Hills, California School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorCorresponding Author
Dr. Jeff E. Borenstein M.D., M.P.H.
Departments of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Cedars-Sinai Health System, Beverly Hills, California School of Medicine, University of California Los Angeles, Los Angeles, California
Health Services Research Department, Cedars-Sinai Health System, 9100 Wilshire Boulevard, East Tower, Suite 655, Beverly Hills, CA 90212; e-mail: [email protected].Search for more papers by this authorDr. Geneen Graber Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Emmanuel Saltiel Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Pharmacy, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Joel Wallace Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Seonyoung Ryu Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Archi Jackson Pharm.D.
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Stephen Deutsch M.D.
Departments of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorDr. Scott R. Weingarten M.D., M.PH.
Departments of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California
Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, California
Cedars-Sinai Health System, Beverly Hills, California School of Medicine, University of California Los Angeles, Los Angeles, California
Search for more papers by this authorAbstract
Objective. To compare the effectiveness of an evidence-based, systematic approach to hypertension care involving comanagement of patients by primary care physicians and clinical pharmacists versus usual care in reducing blood pressure in patients with uncontrolled hypertension.
Methods. Patients in a staff model medical group with uncontrolled hypertension were randomized to either a usual care (UC) or a physician-pharmacist comanagement (PPCM) group. All physicians in the study received both group and individual education and participated in the development of an evidence-based hypertension treatment algorithm. Physicians were then given the names of their patients whose medical records documented elevated blood pressures (defined as systolic ≥ 140 mm Hg and/or diastolic ≥ 90 mm Hg for patients aged < 65 yrs, and systolic ≥ 160 mm Hg and/or diastolic ≥ 90 mm Hg for those aged ≥ 65 yrs). Patients randomized to the UC group were managed by primary care physicians alone. Those randomized to the PPCM group were comanaged by their primary care physician and a clinical pharmacist, who provided patient education, made treatment recommendations, and provided follow-up. Blood pressure measurements, antihypertensive drugs, and visit costs/patient were obtained from medical records.
Results. One hundred ninety-seven patients with uncontrolled hypertension participated in the study. Both PPCM and UC groups experienced significant reductions in blood pressure (systolic −22 and −11 mm Hg, respectively, p<0.01; diastolic −7 and −8 mm Hg, respectively, p<0.01). The reduction in systolic blood pressure was greater in the PPCM group after adjusting for differences in baseline blood pressure between the groups (p<0.01). More patients achieved blood pressure control in the PPCM than in the UC group (60% vs 43%, p=0.02). Average provider visit costs/patient were higher in the UC than the PPCM group ($195 vs $160, p=0.02).
Conclusions. An evidence-based, systematic approach using physician-pharmacist comanagement for patients with uncontrolled hypertension resulted in improved blood pressure control and reduced average visit costs/patient.
References
- 1 Burt VL, Whelton P., Roccella EJ, et al. Prevalence of hypertension in the U.S. adult population: results from the third national health and nutrition examination survey, 1988–1991. Hypertension 1995; 25(3): 305–13.
- 2 Kramarow E., Lentzner H., Rooks R., Weeks J., Saydah S. Health and aging chart book: health, United States, 1999. Hyattsville, MD: National Center for Health Statistics, 1999.
- 3 Stamler J., Stamler R., Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: U.S. population data. Arch Intern Med 1993; 153: 598–615.
- 4 Moser M. Can the cost of care be contained and quality of care maintained in the management of hypertension? Arch Intern Med 1994; 154: 1665–72.
- 5 Lenfant C., Roccella EJ. A call to action for more aggressive treatment of hypertension. J Hypertens 1999; 17(1): S3–7.
- 6 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157(21): 2413–46.
- 7 Collins R., Peto R., MacMahon S., et al. Blood pressure, stroke, and coronary heart disease. Part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335(8693): 827–38.
- 8 MacMahon S., Rogers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15: 967–78.
- 9 Kaplan RC, Psaty BM, Heckbert SR, Smith NL, Lemaitre RN. Blood pressure level and incidence of myocardial infarction among patients treated for hypertension. Am J Public Health 1999; 89(9): 1414–17.
- 10 Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995; 130(3): 572–9.
- 11 Miller NH, Hill M., Kottke T., Ockene IS. The multilevel compliance challenge: recommendations for a call to action: a statement for health care professionals. Circulation 1997; 95(4): 1085–90.
- 12 Klein LE. Compliance and blood pressure control. Hypertension 1988; 11(3 suppl II): II-61–4.
- 13 German PS. Compliance and chronic disease. Hypertension 1988; 11(3 suppl II): II-56–60.
- 14 Caro JJ, Salas MM, Speckman JL, Raggio G., Jackson JD. Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1999; 160(1): 31–7.
- 15 Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991; 2(2): 664–9.
- 16
Beto JA,
Bansal VK.
Quality of life in treatment of hypertension: a meta-analysis of clinical trials.
Am J Hypertens
1995; 5: 125–33.
10.1093/ajh/5.3.125 Google Scholar
- 17 Grimm RH Jr, Grandits GA, Cutler JA, et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study. Arch Intern Med 1997; 157(6): 638–48.
- 18 Wiklund I., Halling K., Ryden-Bergsten T., Fletcher A. Does lowering the blood pressure improve mood? Quality-of-life results from the hypertension optimal treatment (HOT) study. Blood Press 1997; 6(6): 357–64.
- 19 Swales JD. Current clinical practice in hypertension: The EISBERG (evaluation and interventions for systolic blood pressure elevation—regional and global) project. Am Heart J 1999; 138(3 pt 2): S231–7.
- 20 Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Levy D. Differential impact of systolic and diastolic blood pressure level on JNC VI staging: joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 1999; 34(3): 381–5.
- 21 Black HR. Editorial commentary: the paradigm has shifted, to systolic hypertension. Hypertension 1999; 34(3): 386–7.
- 22 Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339(27): 1957–63.
- 23 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1993; 153: 154–83.
- 24 Siegel D., Lopez J. Trends in antihypertensive use in the United States: do JNC V recommendations affect prescribing? JAMA 1997; 278(21): 1745–8.
- 25 Ellrodt G., Cook DJ, Lee J., et al. Evidence-based disease management. JAMA 1997; 278(20): 1687–92.
- 26 Weingarten S. Practice guidelines and prediction rules should be subject to careful clinical testing. JAMA 1997; 277(24): 1977–8.
- 27 Grimshaw J., Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342(8883): 1317–22.
- 28 Grol R., Grimshaw J. Evidence-based implementation of evidence-based medicine. Jt Comm J Qual Improv 1999; 25(10): 503–13.
- 29 McInnes G. Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J 1999; 138(3 Pt 2): S252–5.
- 30 Campbell NC, Ritchie LD, Thain J., Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomized controlled trial of nurse-led clinics in primary care. Heart 1998; 80(5): 447–52.
- 31 Erickson SR, Slaughter R., Halapy H. Pharmacists' ability to influence outcomes of hypertensive therapy. Pharmacotherapy 1997; 17(1): 141–7.
- 32 Bogden PE, Abbott RD, Williamson P., Onopa JK, Koontz LM. Comparing standard care with a physician-pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 1998; 13(11): 740–5.
- 33 Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001; 21(11): 1337–44.
- 34 Godley P., Pham H., Rohack J., Woodward B., Yokoyama K., Maue SK. Opportunities for improving the quality of hypertension care in a managed care setting. Am J Health-Syst Pharm 2001; 58(18): 1728–33.
- 35 Earle KA, Taylor P., Wyatt S., Burnett S., Ray J. A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study. J Hum Hypertens 2001; 15(8): 509–10.
- 36 Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000; 20(11): 1384–9.
- 37
Singhal PK,
Gupchup GV,
Raisch DW,
Schommer JC,
Holdsworth MT.
Impact of pharmacists' directive guidance behaviors on patient satisfaction.
J Am Pharm Assoc
2002; 42(3): 407–12.
10.1331/108658002763316824 Google Scholar